Public Release:  Investigators from Montefiore Medical Center and Albert Einstein College of Medicine to present research data at American Diabetes Association meeting

Studies cover hypoglycemia, behavioral intervention, insulin pump therapy and more

Albert Einstein College of Medicine

NEW YORK (June 25, 2013) - Researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present findings from studies that explore a wide range of topics including hypoglycemia, the benefits of behavioral intervention, insulin pump therapy and fetal outcomes in diabetic women at the annual meeting of the American Diabetes Association, which begins Friday in Chicago.

This year's meeting will feature more than 1,200 presentations by experts on the latest diabetes research. Selected data to be presented by Montefiore/Einstein researchers include:

  • New Findings from Controlled Behavioral Interventions: The Bronx A1c Telephonic Behavioral Intervention Study - Embargoed until time of presentation. Presented by Elizabeth Walker, Ph.D., professor of medicine and of epidemiology and population health, Einstein, at 4:30 pm, June 21. (Abstract # 2-OR, McCormick Place Convention Center, Room W-192B)

  • Hypoglycemia in Hospitalized Patients; Etiology and Prevention - Is Hypoglycemia a Marker or Cause of Death? - Embargoed until 10 am, June 22. Presented by Joel Zonszein, M.D., director, Clinical Diabetes Center, and professor of clinical medicine, Einstein, at 8 am, June 22. (Symposium # AC-SY11, McCormick Place Convention Center W-375 )

  • Resveratrol Improves Insulin Sensitivity in Concert with Reduced Inflammation and "Browning" of White Adipose Tissue in Obese, Insulin Resistant Humans - Embargoed until time of presentation. Presented by Meredith Hawkins, M.D., the Harold and Muriel Block Chair in Medicine at Einstein, and attending physician, endocrinology, Montefiore, at 9:15 am, June 22. (Abstract #99-OR, McCormick Place Convention Center West Bldg. Room W-192B)

Dr. Hawkins' group will present four abstracts at the conference, with the other three examining how the brain regulates metabolism and inflammation.

  • Current State of Insulin Pump Therapy: Combination Infusions - Embargoed until time of presentation. Presented by Rubina Heptulla, M.D., chief, Division of Pediatric Endocrinology and Diabetes, The Children's Hospital at Montefiore, and professor of pediatrics and medicine, Einstein, at 11:15 am, June 25. (Symposium # CT-SY11, McCormick Place Convention Center, West Building - W-196B)

###

Researchers for each of these studies as well as other Montefiore/Einstein faculty who are attending the meeting are available to speak with media.

About Montefiore Medical Center

As the University Hospital for Albert Einstein College of Medicine, Montefiore is a premier academic medical center nationally renowned for its clinical excellence, scientific discovery and commitment to its community. Recognized among the top hospitals nationally and regionally by U.S. News & World Report, Montefiore provides compassionate, patient- and family-centered care and educates the healthcare professionals of tomorrow. The Children's Hospital at Montefiore is consistently named in U.S. News' "America's Best Children's Hospitals," and is second among those in the New York metro area. With four hospitals, 1,491 beds and 90,000 annual admissions, Montefiore is an integrated health system seamlessly linked by advanced technology. State-of-the-art primary and specialty care is provided through a network of more than 130 locations across the region, including the largest school health program in the nation and a home health program. Montefiore's partnership with Einstein advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. The medical center derives its inspiration for excellence from its patients and community, and continues to be on the frontlines of developing innovative approaches to care. For more information please visit http://www.montefiore.org and http://www.montekids.org. Follow us on Twitter; like us on Facebook; view us on YouTube.

About Albert Einstein College of Medicine of Yeshiva University

Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2012-2013 academic year, Einstein is home to 742 M.D. students, 245 Ph.D. students, 116 students in the combined M.D./Ph.D. program, and 360 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates. In 2012, Einstein received over $160 million in awards from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center -Einstein's founding hospital, and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn, Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States. For more information, please visit http://www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.